SCHEMBL8034874

SCHEMBL8034874

CCNc1nc2ccc(C)cc2o1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.56
KDM4E B2RXH2 7/20 0.56
HSD17B10 Q99714 5/20 0.49
FBP1 P09467 1/20 0.47
ALDH1A1 P00352 7/20 0.46
TDP1 Q9NUW8 2/20 0.46
LMNA P02545 1/20 0.46
AGTR1 P30556 1/20 0.46
OPRK1 P41145 1/20 0.46
MDM2 Q00987 1/20 0.46
HIF1A Q16665 1/20 0.46
NPC1 O15118 11/20 0.46
RAB9A P51151 11/20 0.46
SMN1; SMN2 Q16637 6/20 0.46
ELANE P08246 2/20 0.46
USP2 O75604 1/20 0.46
MAPK10 P53779 1/20 0.46
HPGD P15428 5/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3822363 0.87 RAB9A (0.59) MAPTKDM4EHSD17B10FBP1ALDH1A1
SCHEMBL12755430 0.80 CSNK1D (0.49) MAPTFBP1ELANEMEN1KMT2A
SCHEMBL2134640 0.79 MAPT (0.54) MAPTKDM4EHSD17B10FBP1ALDH1A1
SCHEMBL2544239 0.79 KDM4E (0.48) MAPTKDM4EHSD17B10FBP1ALDH1A1
SCHEMBL29045541 0.78 ELANE (0.44) MAPTKDM4EFBP1ALDH1A1NPC1
SCHEMBL11451768 0.77 ELANE (0.61) MAPTALDH1A1LMNANPC1RAB9A
SCHEMBL2841557 0.77 TTR (0.49) MAPTKDM4EALDH1A1TDP1LMNA
SCHEMBL11261015 0.75 MAPT (0.50) MAPTKDM4EHSD17B10FBP1ALDH1A1
SCHEMBL5535594 0.75 MAPT (0.83) MAPTKDM4EHSD17B10ALDH1A1TDP1
SCHEMBL8370275 0.74 NPC1 (0.66) MAPTKDM4EHSD17B10ALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8637542-B2 Kinase inhibitors and methods of use INTELLIKINE, INC. (US) 2014-01-28 US disclosed
WO-2009114870-A2 KINASE INHIBITORS AND METHODS OF USE INTELLIKINE, INC. (US) 2009-09-17 WO disclosed